top of page
ABOUT
Dr. Amy Pomeroy is a computational pharmacologist. Her research focuses on using mathematical modeling to understand and predict clinical outcomes of cancer treatments with the goal of informing and optimizing clinical trial design. Her work spans mutliple cancer types and treatment modalities including chemotherapy, immunotherapy, and CAR T-cell therapy. Dr. Pomeroy prioritizes collaborative, multidisciplinary research, working closely with other researchers and clinicians to maximize the translational impact of her research projects.
HIGHLIGHTED PUBLICATIONS
A novel modeling approach that integrates both intra-tumor and inter-patient heterogeneity explains and predicts clinical trials of curative combination therapy
​
Published in Blood Cancer Discovery
GET IN TOUCH
bottom of page